Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
- PMID: 38702756
- PMCID: PMC11067317
- DOI: 10.1186/s12967-024-05169-9
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
Abstract
The onerous health and economic burden associated with head and neck squamous cell carcinoma (HNSCC) is a global predicament. Despite the advent of novel surgical techniques and therapeutic protocols, there is an incessant need for efficacious diagnostic and therapeutic targets to monitor the invasion, metastasis and recurrence of HNSCC due to its substantial morbidity and mortality. The differential expression patterns of histone deacetylases (HDACs), a group of enzymes responsible for modifying histones and regulating gene expression, have been demonstrated in neoplastic tissues. However, there is limited knowledge regarding the role of HDACs in HNSCC. Consequently, this review aims to summarize the existing research findings and explore the potential association between HDACs and HNSCC, offering fresh perspectives on therapeutic approaches targeting HDACs that could potentially enhance the efficacy of HNSCC treatment. Additionally, the Cancer Genome Atlas (TCGA) dataset, CPTAC, HPA, OmicShare, GeneMANIA and STRING databases are utilized to provide supplementary evidence on the differential expression of HDACs, their prognostic significance and predicting functions in HNSCC patients.
Keywords: Epigenetic therapy; Head and neck squamous cell carcinoma; Histone deacetylases; Mechanism.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.J Exp Clin Cancer Res. 2019 Feb 18;38(1):84. doi: 10.1186/s13046-019-1080-8. J Exp Clin Cancer Res. 2019. PMID: 30777099 Free PMC article.
-
Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.Mol Genet Genomic Med. 2019 Aug;7(8):e857. doi: 10.1002/mgg3.857. Epub 2019 Jul 15. Mol Genet Genomic Med. 2019. PMID: 31304688 Free PMC article.
-
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.Oral Oncol. 2020 Dec;111:104930. doi: 10.1016/j.oraloncology.2020.104930. Epub 2020 Jul 31. Oral Oncol. 2020. PMID: 32745900
-
Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.Epigenomics. 2022 Mar;14(5):279-293. doi: 10.2217/epi-2020-0348. Epub 2022 Feb 21. Epigenomics. 2022. PMID: 35184601 Review.
-
Histone modifications in head and neck squamous cell carcinoma.Front Oncol. 2024 Jun 25;14:1427725. doi: 10.3389/fonc.2024.1427725. eCollection 2024. Front Oncol. 2024. PMID: 38983924 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous